Literature DB >> 23480193

Ex-vivo analysis of human natural killer T cells demonstrates heterogeneity between tissues and within established CD4(+) and CD4(-) subsets.

A C Chan1, E Leeansyah, A Cochrane, Y d'Udekem d'Acoz, D Mittag, L C Harrison, D I Godfrey, S P Berzins.   

Abstract

Our understanding of human type 1 natural killer T (NKT) cells has been heavily dependent on studies of cells from peripheral blood. These have identified two functionally distinct subsets defined by expression of CD4, although it is widely believed that this underestimates the true number of subsets. Two recent studies supporting this view have provided more detail about diversity of the human NKT cells, but relied on analysis of NKT cells from human blood that had been expanded in vitro prior to analysis. In this study we extend those findings by assessing the heterogeneity of CD4(+) and CD4(-) human NKT cell subsets from peripheral blood, cord blood, thymus and spleen without prior expansion ex vivo, and identifying for the first time cytokines expressed by human NKT cells from spleen and thymus. Our comparative analysis reveals highly heterogeneous expression of surface antigens by CD4(+) and CD4(-) NKT cell subsets and identifies several antigens whose differential expression correlates with the cytokine response. Collectively, our findings reveal that the common classification of NKT cells into CD4(+) and CD4(-) subsets fails to reflect the diversity of this lineage, and that more studies are needed to establish the functional significance of the antigen expression patterns and tissue residency of human NKT cells.
© 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23480193      PMCID: PMC3719939          DOI: 10.1111/cei.12045

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression.

Authors:  Chang H Kim; Eugene C Butcher; Brent Johnston
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

Review 2.  NKT cells: what's in a name?

Authors:  Dale I Godfrey; H Robson MacDonald; Mitchell Kronenberg; Mark J Smyth; Luc Van Kaer
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

Review 3.  Going both ways: immune regulation via CD1d-dependent NKT cells.

Authors:  Dale I Godfrey; Mitchell Kronenberg
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

4.  Cutting edge: analysis of human V alpha 24+CD8+ NK T cells activated by alpha-galactosylceramide-pulsed monocyte-derived dendritic cells.

Authors:  Tsuyoshi Takahashi; Shigeru Chiba; Mie Nieda; Takeshi Azuma; Soichiro Ishihara; Yoichi Shibata; Takeo Juji; Hisamaru Hirai
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

5.  NKT cells are phenotypically and functionally diverse.

Authors:  K J Hammond; S B Pelikan; N Y Crowe; E Randle-Barrett; T Nakayama; M Taniguchi; M J Smyth; I R van Driel; R Scollay; A G Baxter; D I Godfrey
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

6.  Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7.

Authors:  Johan K Sandberg; Cheryl A Stoddart; Fabienne Brilot; Kimberly A Jordan; Douglas F Nixon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

7.  Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood: implications for human studies.

Authors:  Stuart P Berzins; Kon Kyparissoudis; Daniel G Pellicci; Kristen J Hammond; Stephane Sidobre; Alan Baxter; Mark J Smyth; Mitchell Kronenberg; Dale I Godfrey
Journal:  Immunol Cell Biol       Date:  2004-06       Impact factor: 5.126

8.  NKT cells from normal and tumor-bearing human livers are phenotypically and functionally distinct from murine NKT cells.

Authors:  Tony Kenna; Lucy Golden-Mason; Steven A Porcelli; Yasuhiko Koezuka; John E Hegarty; Cliona O'Farrelly; Derek G Doherty; Lucy Golden Mason
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

9.  Distinct and overlapping effector functions of expanded human CD4+, CD8α+ and CD4-CD8α- invariant natural killer T cells.

Authors:  Vincent O'Reilly; Shijuan G Zeng; Gabriel Bricard; Ann Atzberger; Andrew E Hogan; John Jackson; Conleth Feighery; Steven A Porcelli; Derek G Doherty
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

10.  Distinct functional lineages of human V(alpha)24 natural killer T cells.

Authors:  Peter T Lee; Kamel Benlagha; Luc Teyton; Albert Bendelac
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  27 in total

Review 1.  Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge.

Authors:  Daniel G Pellicci; Hui-Fern Koay; Stuart P Berzins
Journal:  Nat Rev Immunol       Date:  2020-06-24       Impact factor: 53.106

Review 2.  The burgeoning family of unconventional T cells.

Authors:  Dale I Godfrey; Adam P Uldrich; James McCluskey; Jamie Rossjohn; D Branch Moody
Journal:  Nat Immunol       Date:  2015-11       Impact factor: 25.606

3.  Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host disease.

Authors:  Abel Trujillo-Ocampo; Hyun-Woo Cho; Amanda C Herrmann; Wilfredo Ruiz-Vazquez; Andrew B Thornton; Hong He; Dan Li; Mariam A Qazilbash; Qing Ma; Steven A Porcelli; Elizabeth J Shpall; Jeffrey Molldrem; Jin S Im
Journal:  Cytotherapy       Date:  2018-07-31       Impact factor: 5.414

4.  Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy.

Authors:  A C Chan; P Neeson; E Leeansyah; K Tainton; H Quach; H M Prince; S J Harrison; D I Godfrey; D Ritchie; S P Berzins
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

5.  Human CD4- invariant NKT lymphocytes regulate graft versus host disease.

Authors:  Tereza Coman; Julien Rossignol; Maud D'Aveni; Bettina Fabiani; Michael Dussiot; Rachel Rignault; Joel Babdor; Marie Bouillé; André Herbelin; Francine Coté; Ivan C Moura; Olivier Hermine; Marie-Thérèse Rubio
Journal:  Oncoimmunology       Date:  2018-08-23       Impact factor: 8.110

6.  West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells.

Authors:  S Kovats; S Turner; A Simmons; T Powe; E Chakravarty; J Alberola-Ila
Journal:  Clin Exp Immunol       Date:  2016-09-22       Impact factor: 4.330

7.  A Diverse Lipid Antigen-Specific TCR Repertoire Is Clonally Expanded during Active Tuberculosis.

Authors:  William S DeWitt; Krystle K Q Yu; Damien B Wilburn; Anna Sherwood; Marissa Vignali; Cheryl L Day; Thomas J Scriba; Harlan S Robins; Willie J Swanson; Ryan O Emerson; Philip H Bradley; Chetan Seshadri
Journal:  J Immunol       Date:  2018-06-18       Impact factor: 5.422

Review 8.  A multilayered immune system through the lens of unconventional T cells.

Authors:  Toufic Mayassi; Luis B Barreiro; Jamie Rossjohn; Bana Jabri
Journal:  Nature       Date:  2021-07-21       Impact factor: 49.962

9.  Human skin is colonized by T cells that recognize CD1a independently of lipid.

Authors:  Rachel N Cotton; Tan-Yun Cheng; Marcin Wegrecki; Jérôme Le Nours; Dennis P Orgill; Bohdan Pomahac; Simon G Talbot; Richard A Willis; John D Altman; Annemieke de Jong; Graham Ogg; Ildiko Van Rhijn; Jamie Rossjohn; Rachael A Clark; D Branch Moody
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

10.  Exploratory Evaluation of the Relationship Between iNKT Cells and Systemic Cytokine Profiles of Critically Ill Patients with Neurological Injury.

Authors:  David A Zygun; Paul Kubes; Brittney N V Scott; Andreas H Kramer; Rita Nguyen; Connie H Y Wong; Craig N Jenne; Stacy Ruddell; Josee Wong; Mandy Tse; Brent W Winston; Andrea Soo; Christopher J Doig
Journal:  Neurocrit Care       Date:  2021-06-01       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.